On the recordSeptember 20, 2016
The bottom line is you took a very inexpensive drug and you profited handsomely off it.
Source
congress.govEditor's note · Context
DesJarlais criticizes the high pricing of EpiPens despite their low cost.
Share
More from Scott DesJarlais
Apr 17, 2023
Do you think President Xi has been ambiguous at all in his intentions on Taiwan?
Mar 27, 2023
I think that there is no one in this room that can't look at the news and agree that we have a problem at our southern border with illegals flowing in.
May 19, 2019
What will USDA's involvement be in both this case and in preventing the spread of EP in the United States?
Mar 27, 2023
So we have had roughly five million border crossings since President Biden took office.
Other voices in this conversation
